Literature DB >> 19717524

MyD88 adaptor-like is not essential for TLR2 signaling and inhibits signaling by TLR3.

Elaine F Kenny1, Suzanne Talbot, Mei Gong, Douglas T Golenbock, Clare E Bryant, Luke A J O'Neill.   

Abstract

Although a clear role for the adaptor protein myeloid differentiation factor-88 (MyD88) adaptor-like (Mal, or TIRAP) in TLR4 signaling has been demonstrated, there is limited information on its role in TLR2 signaling. Here we have systematically analyzed the role of Mal in signaling by TLR2, TLR4, and as a control TLR3 in murine macrophages and dendritic cells. Mal was not required for the induction of IL-6 or NFkappaB activation at high concentrations of the TLR1/2 ligand Pam(3)Cys-Ser-(Lys)(4) or the TLR2/6 ligand macrophage-activating lipopeptide-2 and was required for these responses only at low ligand concentrations. Similarly, induction of IL-6 by Salmonella typhimurium, which is sensed by TLR2, required Mal only at low levels of bacteria. Mal was required for IL-6 induction at all concentrations of the TLR4 ligand LPS. Mal deficiency boosted IL-6 induction by the TLR3 ligand polyinosinic-polycytidylic acid. Activation of JNK, but not p38 or IkappaB degradation, was similarly potentiated in response to polyinosinic-polycytidylic acid in Mal-deficient macrophages. MyD88 was vital for all TLR2 and TLR4 responses and, similar to Mal, was also inhibitory for TLR3-dependent IL-6 and JNK induction. MyD88 interacted with the Toll/IL-1R domains of TLR1, TLR2, TLR4, and TLR6. Mal interacted with the Toll/Il-1R domains of TLR1, TLR2, and TLR4 but not with TLR6. Our study, therefore, reveals that Mal is dispensable in TLR2 signaling at high ligand concentrations in macrophages and dendritic cells, with MyD88 probably coupling to the TLR2 receptor complex at sufficient levels to allow activation. An inhibitory role for Mal in TLR3 signaling to JNK was also demonstrated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19717524     DOI: 10.4049/jimmunol.0901140

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor.

Authors:  Hulda Sigridur Hreggvidsdóttir; Anna M Lundberg; Ann-Charlotte Aveberger; Lena Klevenvall; Ulf Andersson; Helena Erlandsson Harris
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

2.  Nuclear factor κB subunits RelB and cRel negatively regulate Toll-like receptor 3-mediated β-interferon production via induction of transcriptional repressor protein YY1.

Authors:  Jakub Siednienko; Ashwini Maratha; Shuo Yang; Malgorzata Mitkiewicz; Sinéad M Miggin; Paul N Moynagh
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

3.  Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling.

Authors:  Leah E Cole; Michelle H W Laird; Anna Seekatz; Araceli Santiago; Zhaozhao Jiang; Eileen Barry; Kari Ann Shirey; Katherine A Fitzgerald; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2009-11-04       Impact factor: 4.962

4.  Solution structure of the TLR adaptor MAL/TIRAP reveals an intact BB loop and supports MAL Cys91 glutathionylation for signaling.

Authors:  Mark M Hughes; Peter Lavrencic; Rebecca C Coll; Thomas Ve; Dylan G Ryan; Niamh C Williams; Deepthi Menon; Ashley Mansell; Philip G Board; Mehdi Mobli; Bostjan Kobe; Luke A J O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

Review 5.  Innate immune pattern recognition: a cell biological perspective.

Authors:  Sky W Brubaker; Kevin S Bonham; Ivan Zanoni; Jonathan C Kagan
Journal:  Annu Rev Immunol       Date:  2015-01-02       Impact factor: 28.527

6.  14-3-3ε and 14-3-3σ inhibit Toll-like receptor (TLR)-mediated proinflammatory cytokine induction.

Authors:  Aisha Qasim Butt; Suaad Ahmed; Ashwini Maratha; Sinéad M Miggin
Journal:  J Biol Chem       Date:  2012-09-14       Impact factor: 5.157

7.  Toll/interleukin-1 receptor domain dimers as the platform for activation and enhanced inhibition of Toll-like receptor signaling.

Authors:  Ota Fekonja; Mojca Benčina; Roman Jerala
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

Review 8.  The history of Toll-like receptors - redefining innate immunity.

Authors:  Luke A J O'Neill; Douglas Golenbock; Andrew G Bowie
Journal:  Nat Rev Immunol       Date:  2013-05-17       Impact factor: 53.106

9.  Uncoupling of pro- and anti-inflammatory properties of Staphylococcus aureus.

Authors:  Adam G Peres; Camille Stegen; Junbin Li; An Qi Xu; Benoit Levast; Michael G Surette; Benoit Cousineau; Martin Desrosiers; Joaquín Madrenas
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

10.  The small GTPase Arf6 is essential for the Tram/Trif pathway in TLR4 signaling.

Authors:  Tim Van Acker; Sven Eyckerman; Lieselotte Vande Walle; Sarah Gerlo; Marc Goethals; Mohamed Lamkanfi; Celia Bovijn; Jan Tavernier; Frank Peelman
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.